The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
buying building again
good research being posted here ,helpful for some one like myself who doing more researching
the more i read this rns ,the happy i am to hold d y o r
Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive® 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit.
The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.
The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.
Will another intraday rns be released ,will we see another TRI
looking like a good week for covid shares with odx moving up more ,also gdr so many loading up there before mid month
as that rns
good start to week
20,000 share buy
Ticking up some more ,looking like a strong week here at weir getting distracted with watching gdr so many buyers moving in there again Today as it looking like more people wanting to be holding that share before mid month .like how weir starting of this week ,like a blue start to a week
Ticking up some more , getting distracted with watching gdr so many buyers moving in there again Today as it looking like more people wanting to be holding that share before mid month .like how aal starting of this week ,like a blue start to a week .
Good blue start to this week .
looking strong again Today .
Ticking up more ,
Good to see how this moving up Today
Buyers pushing this up nicely ,
like how the sellers below and around £1 ,important to see sellers cleared at each level for people like myself who investing
in gdr with a longer term view .
Strong buying ,this 5000 share buyer still buying so many chunks of shares Today
Moving up again
buyers loading again
AN AMAZING RNS
even this part of the rns
Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing
David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.
"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."
The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.
£1 already Today
hoping for a good finish here ,also at gdr more buyers look to loading up to be in before next week ,